Hydrochloric Acid → 5-Chloro-4-[(6-chloro-2'-fluoro-4-pyridazin-4-ylbiphenyl-3-yl)oxy]-2-fluoro-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide
Reaction equation
Cl.O1CCOCC1.[Cl:8][C:9]1[C:10]([O:36][C:37]2[CH:38]=[C:39]([C:50]3[CH:55]=[CH:54][CH:53]=[CH:52][C:51]=3[F:56])[C:40]([Cl:49])=[CH:41][C:42]=2[C:43]2[CH:48]=[CH:47][N:46]=[N:45][CH:44]=2)=[CH:11][C:12]([F:35])=[C:13]([S:15]([N:18](CC2C=CC(OC)=CC=2OC)[C:19]2[S:20][CH:21]=[N:22][N:23]=2)(=[O:17])=[O:16])[CH:14]=1>CO>[Cl:8][C:9]1[C:10]([O:36][C:37]2[CH:38]=[C:39]([C:50]3[CH:55]=[CH:54][CH:53]=[CH:52][C:51]=3[F:56])[C:40]([Cl:49])=[CH:41][C:42]=2[C:43]2[CH:48]=[CH:47][N:46]=[N:45][CH:44]=2)=[CH:11][C:12]([F:35])=[C:13]([S:15]([NH:18][C:19]2[S:20][CH:21]=[N:22][N:23]=2)(=[O:17])=[O:16])[CH:14]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Hydrogen chloride in dioxane (4M, 1.5 mL, 6.00 mmol) was added to a solution of 5-chloro-4-(6-chloro-2′-fluoro-4-(pyridazin-4-yl)biphenyl-3-yloxy)-N-(2,4-dimethoxybenzyl)-2-fluoro-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide (Preparation 92, 220 mg, 0.27 mmol) in methanol (1.5 mL) and the reaction stirred at room temperature for 18 hours. The mixture was evaporated to dryness and dissolved in dimethylsulfoxide (4.0 mL) and methanol (2.0 mL). The resulting precipitate was filtered, washed with methanol (2.0 mL) and the filtrate purified by preparative HPLC using a Phenomenex Luna C18 5 u 110 A 21.2×150 mm using acetonitrile:water as eluent to give the title compound (92 mg, 56%) as a beige coloured solid.
Workup
- customThe mixture was evaporated to dryness
- dissolutiondissolved in dimethylsulfoxide (4.0 mL)
- filtrationThe resulting precipitate was filtered
- washwashed with methanol (2.0 mL)
- customthe filtrate purified by preparative HPLC
Sources & evidence
- ORD record
- ord-79e441789e53422fb72c789f66e0d7f0
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08772293B2
Reaction notes
Loading…